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Abstract
Background: The eukaryotic RNase ribonuclease/angiogenin inhibitors (RI) are a protein group distinguished by a
unique structure - they are composed of hydrophobic leucine-rich repeat motifs (LRR) and contain a high amount
of reduced cysteine residues. The members of this group are difficult to produce in E. coli and other recombinant
hosts due to their high aggregation tendency.
Results: In this work dithiothreitol (DTT) was successfully applied for improving the yield of correctly folded
ribonuclease/angiogenin inhibitor in E. coli K12 periplasmic and cytoplasmic compartments. The feasibility of the in
vivo folding concepts for cytoplasmic and periplasmic production were demonstrated at batch and fed-batch
cultivation modes in shake flasks and at the bioreactor scale.
Firstly, the best secretion conditions of RI in the periplasmic space were evaluated by using a high throughput
multifactorial screening approach of a vector library, directly with the Enbase fed-batch production mode in
96-well plates. Secondly, the effect of the redox environment was evaluated in isogenic dsbA+ and dsbA- strains at
the various cultivation conditions with reducing agents in the cultivation medium. Despite the fusion to the signal
peptide, highest activities were found in the cytoplasmic fraction. Thus by removing the signal peptide the positive
effect of the reducing agent DTT was clearly proven also for the cytoplasmic compartment. Finally, optimal
periplasmic and cytoplasmic RI fed-batch production processes involving externally added DTT were developed in
shake flasks and scaled up to the bioreactor scale.
Conclusions: DTT highly improved both, periplasmic and cytoplasmic accumulation and activity of RI at low
synthesis rate, i.e. in constructs harbouring weak recombinant synthesis rate stipulating genetic elements together
with cultivation at low temperature. In a stirred bioreactor environment RI folding was strongly improved by
repeated pulse addition of DTT at low aeration conditions.
Background
Escherichia coli is the most widely used host for recom-
binant protein production. Aggregation of the target
protein in E. coli is a common phenomenon which is a
consequence of the inability of the host’s folding
machinery to cope with the rapidly accumulating target
protein folding and/or to facilitate efficient stabilization
of SH groups, or to contribute to the formation and/or
reorganization of correct disulfide bonds.
Contrary to most cases reported in literature, which
focussed on the enhancement of disulfide bond forma-
tion in recombinant proteins by modulating the redox
situation, we found it challenging to improve the folding
of eukaryotic ribonuclease inhibitor RI (~49 kDa) which
is characterised by a high amount of reduced cysteins,
which are vital for the function of the protein. Our
model protein - RI, shows a homology of 79-82% to the
well characterized RNase ribonuclease/angiogenin inhi-
bitors from human (hRI), rat (rRI), mouse (mRI) and
porcine (pRI). The members of the ribonuclease inhibi-
tor group represent a specific subfamily within the large
group of proteins with a very special protein fold - the
leucine-rich repeat (LRR) proteins [1]. LRR proteins
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share very interesting features which makes them a
unique group of proteins. RI has an unusual non-
globular flexible horseshoe like structure, which is very
conserved between different species. The core of RI
molecules is composed of hydrophobic 15-16 LRR
motifs. Each of the LRR’s consists of a structural unit of
28 to 29 amino acids forming an a-helix and b-strand
connected by loops [2]. RI has a very high leucine con-
tent (18%), but also contains 30-32 cysteine residues
(6.5-7%). In difference to other LRR motif containing
proteins where the cysteins are structural units (see e.g.
[3]), all cysteins in RI are reduced which is very impor-
tant for activity, i.e. substate interaction. Oxidation of
free SH groups in RI is highly cooperative and leads to
inactivation and even denaturation [2,4].
Production of RI has been a challenge due to its flex-
ible structure, repetetive amino acids and reduced
cysteins. Thus so far reported RI production attempts in
the yeast Saccharomyces cerevisiae [5] and in E. coli
[6,7] resulted in a low overall yield either due to a low
production level and/or high RI insolubility, respectively.
So far about 10 mg of active porcine RI (pRI) per liter
of culture medium was produced by using the Ptrp pro-
moter in the E. coli host [7].
Recently, after high throughput multifactorial screen-
ing of an E. coli plasmid vector library which contained
different promoters, ribosome binding sites and various
fusion partners, we indentified factors which allowed us
to obtain high amounts of soluble RI only in fusion with
a MBP tag [8]. A fed-batch process was developed with
the most favourable vector yielding about 800 mg of
MBP-RI fusion protein per litre of mineral salt medium,
which corresponds to 425 mg of RI. A similar result
were recently published by Guo et al. [9]. The authors,
in agreement with our earlier results, found the MBP
tag the most suitable partner for soluble RI accumula-
tion [9]. A drawback of this fusion however is that the
inhibitory activity of the MBP-RI fusion towards RNaseA
is 12-fold decreased compared to untagged RI [8]. How-
ever, despite high level production, all other cytoplasmic
constructs containing untagged RI or RI fused to GST,
SUMO and thioredoxin (TRX) showed high aggregation
levels, independently from the transcriptional or transla-
tional control units which were varied in the constructs
[8]. Based on these results we suspected that the above
mentioned molecular features of RI - their sensitivity to
the redox environment and hydrophobicity, or a combi-
nation of both, could be the main causes stipulating
aggregation in the E. coli cells.
In this work we applied RI production strategies
which were more focused on gaining knowledge and
understanding about the significance of reduced SH
groups for RI folding and its activity in E. coli cells. To
manipulate RI folding we used the classical in vivo
approach, which is based on supplementation of the cul-
tivation medium with low molecular weight SH group
acting materials.
So far, to our knowlege, all cases targeting on the
improvement of the folding of recombinant proteins with
folding aiding medium additives were performed with the
aim to improve disulfide bond formation. Partially SH-
group modifying agents were applied in combination with
other stabilising agents. For example reduced/oxidized
glutathione (GSH/GSSG) and arginine can easily penetrate
the outer membrane and act in the periplasmic space on
the folding of disulfide bond containing recombinant pro-
teins [10](for review see [11]). Analogically, but more
sophisticated in vivo folding approaches in the periplasmic
space were based on the utilization of low molecular addi-
tives in tandem with co-secreted chaperones [12], or over-
expression of the prokaryotic disulfide oxidoreductase
DsbA [13], or disulfide isomerases, such as DsbC or eukar-
yotic protein disulfide isomerase (PDI) [14].
In difference to the periplasmic space, the cytoplasm is
considered to be reduced and thus should be the pre-
ferred compartment for expressing a protein which con-
trains reduced cysteins. Externally added components
can also affect the cytoplasm, as was reported by Gill et
al. [15]. Folding and activtiy of chloramphenicol acetyl-
transferase (CAT) in the cytoplasmic space was altered
due the presence of dithiothreitol (DTT) in the cultiva-
tion medium, i.e. DTT is also applicable to influence the
redox state in the cytoplasm and consequently may be
applicable for folding control in the cytoplasm.
By taking these earlier folding cases into account, and
also considering the RI structural aspects, our intention
was to generate and control a favourable redox situation
for RI folding in the cytoplasmic and periplasmic com-
partments by applying reduced glutathione which is act-
ing in the periplasmic space, and respectively,
membrane permeable DTT which is acting in both com-
partments. This is highly interesting, as so far all studies
only improved the redox conditions during periplasmic
production by using the above mentioned methodolo-
gies. Also, all approaches aimed for disulfide production
rather than keeping cysteins in a reduced state. Here, to
our knowledge, for the first time we show the efficiency
of this approach also for the production of proteins
which need a strongly reducing environment. Surpris-
ingly this approach worked well not only for periplasmic
production, but also was necessary and working for
cytoplasmic production. Aside from showing the feasi-
bility of this approach at the example of an RI we go
one step further and demonstrate that this approach is
well suited also as a production strategy in typical fed-
batch processes.
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Results
The aim of the study was to produce correctly folded
RNase Inhibitor (RI) in E. coli. We aimed to test
whether it would be possible to produce RI as an
authentic active protein (without any fusion) in the peri-
plasmic or cytoplasmic compartments. We presumed
that it would be possible to control the conditions in
the periplasmic and cytoplasmic space by either process
parameters or chemical additives.
Library screening in 96 well plates
In order to evaluate the best conditions for secretion of
RI to the periplasmic space of E. coli, the RI gene was
cloned by Gateway cloning into a periplasmic expression
library which was earlier described [16]. This library
contains a set of 36 different ColE1-derived plasmid vec-
tors being a full factorial combination of three varying
parameters: each three different IPTG inducible promo-
ters and ribosome binding sites of different strength,
and four well known signal peptides for translocation of
the product protein into the peripasmic space. The RI
gene harboring set of plasmids was transformed to the
E. coli K-12 strain RV308 which additionally contained
the plasmid pLT1 based reporter system for the moni-
toring of periplasmic folding stress by a degP promoter
controlled luciferase cassette [16]. The s24 dependent
degP promoter is induced by periplasmic folding stress,
i.e. if the protein of interest would aggregate during the
accumulation in the periplasmic space.
As in our earlier study the initial screening experi-
ments were performed in 96-well plates. For obtaining
(i) well controlled conditions, (ii) enough cell material, i.
e. high cell densities, and (iii) additionally applying stra-
tegies which would be applicable in the fermentation
scale later, again, we were applying the EnBase cultiva-
tion technique in MWPs with pure mineral salt medium
and starch-derived glucose as carbon source (cf. [8,17]).
The EnBase-gel containing MWPs were directly inocu-
lated with glycerol stocks of all 36 strains. Periplasmic
RI synthesis was induced after 12 hours of cultivation by
IPTG (Figure 1), the temperature was decreased to 22°C
and 5 h later the cultures were harvested.
All constructs showed a good accumulation of RI.
Remarkably, a 20-30% higher yield of RI was detected in
the strains carrying vectors with the stronger promoters
(pCU, pCTU) in combination with the strongest ribo-
some binding site (T7)(gels images not shown). How-
ever, unexpextedly, all samples showed a very low
activity, independently on the expression strength or sig-
nal peptide (gels images and graphs not shown). These
results would suggest that RI is expressed, but accumu-
lated in inclusion bodies in all cases. However, intrerest-
ingly this was not reflected by the luminescence signals
in the different strains (cf. Figure 1). High luminescence
signals were not connected to high RI accumulation
levels (i.e. aggregated RI), but opposite - higher lumines-
cence values were generated in the strains with the
weaker promoters (pCU, pC) in combination with the
weaker ribosome binding sites (var, lac). Therefore we
consider for RI the periplasmic folding stress reporter
system is not applicable to identify conditions for solu-
ble periplasmic RI accumulation. This is clearly different
to the earlier used cytoplasmic monitoring system [8]
and to the results by Kraft et al. [16] with the scFv-min-
iantibody-phosphatase fusion and 11-b-hydroxysteroid
dehydrogenase type 2 which were expressed in the same
periplasmic expression library.
Figure 1 Growth with EnBase in MWPs of a library of
36 constructs with periplasmic RI production and luciferase
activity of the different clones. A: OD600’s are shown for all
cultures of the vector library. Label sizes represent promoter
strength [from weakest (pC, smallest labels) to strongest (pCTU,
largest labels)]. Label shapes and colours represent ribosome
binding strengths: T7 (red squares), lac (black triangle), var (blue
triangle). Sizes and colours of the specific growth rate labels (circles)
also indicate promoter and ribosome binding site strengths. B: The
periplasmic aggregation signal measured as luminescence in
samples of the RI expression library 5 h after induction. The data
represent three independent cultivation experiments of the whole
library.
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It may be worth to mention that the culture growth
after induction of RI is dependent on the strength of
product synthesis. The cell growth after RI induction of
the clones harboring vectors with the higher synthesis
rate stipulating elements, i.e. pCU, PCTU and T7, was
strongly inhibited compared to cultures harboring vec-
tors with weaker expression elements (pC, pCU, lac,
var) which continued to grow (Figure 1).
Addition of reducing compounds
In summary, the first set of experiments showed that RI
is well produced with some of the constructs, but that
the product is neither active nor soluble. One major rea-
son for the aggregation during recombinant production
in E. coli could be the inability of the expression host to
stably maintain the SH groups of the target RI. There-
fore, we decided to supplement the cultivation medium
with low molecular weight SH group stabilizing agents,
such as DTT and reduced glutathione (GSH). Both are
known to easily access the periplasmic space. Addition-
ally, in parallel, target RI sensitivity to oxidation during
the periplasmic accumulation was tested with and with-
out reducing agents in an isogenic dsbA knockout
mutant of the RV308 strain.
All these second round experiments were performed in
shake flasks, with only a part of the set of plasmid con-
structs. The study was continued with the clones which
during the screening in 96-well microwell plates resulted
in the highest (pCUvar with malE, ompA, phoA signal
peptides; and the pCUlac promoter with the pelB signal
peptide - referred as the “first group”) and the lowest
luminescence levels (pCTUT7- malE, ompA, phoA, pelB
- referred as the “second group”), respectively.
Cultivations were performed in glucose-MSM as
described in the Material and Methods part. At the time
of induction the cultivation medium was supplemented
with the reducing agents DTT or GSH, respectively, in
different concentrations. The results showed no effect
on RI activity or improvement of RI accumulation in
the soluble fraction in the cultures with 20 or 50 mM of
GSH (graphs not shown). Only DTT resulted in a signif-
icant improvement of RI accumulation in the soluble
fraction and also in an increased RI activity in both,
dsbA- and dsbA+, strains (Figures 2, 3). SDS-PAGE ana-
lysis of protein fractions from cultures with addition of
DTT revealed an increasing intensity of 2 bands; their
molecular sizes were corresponding to RI with a signal
sequence (53 kDa) and without (50 kDa). The identity
of the processed RI (50 kDa protein) was confirmed by
N-terminal sequencing of 6 amino acids.
SDS-PAGE analysis showed that the highest amounts
of unprocessed (app. 28 mg gCDW-1) and processed RI
(app. 12 mg gCDW-1) were obtained in the RV308 dsbA+
strain in the soluble protein fraction when the cultivation
was performed with the pCUlac-pelB-RI vector with
12 and 18 mM of DTT. Under these conditions the yield
of processed and even of unprocessed soluble RI protein
was improved by 2 to 2.5-fold compared to the control
without DTT (Figure 2). Different amounts of DTT did
not affect the total amount of accumulated RI in
the dsbA+ strain, but both, DTT and GSH, had a highly
negative impact on the growth and RI yield in the dsbA-
strain.
After periplasmic production without DTT in the
medium, RI activity was detected only in the dsbA-
strains (Figure 4). Depending on the DTT concentration
in the medium, total (soluble and insoluble) RI amounts
in the dsbA- strain constructs were 2 to 4-fold lower
compared to the controls without reducing agents
(Figure 3). The negative effect of DTT on the accumula-
tion of RI resulted also in a lower activity; cultures with
18 mM of DTT showed a 2 to 3-fold lower activity
compared to the cultures with 12 mM DTT (Figure 4).
Despite their bad DTT tolerance, the yield of pro-
cessed RI was improved in all dsbA- constructs when a
lower DTT concentration was used (6 and 12 mM). In
the dsbA- strains the highest yields of processed and
soluble RI (app. 7 mg gCDW-1) were obtained with the
pCUvar-malE construct. In the other constructs the
yield was 10 to 20% lower (Figure 2). In the dsbA-
strains the yield of unprocessed RI was very similar for
all constructs, but indeed 2 to 4-fold lower compared to
the dsbA+ strain. Also, the amounts of processed RI
were highest in the dsbA+ strain (30% higher than in the
dsbA- strain) (Figures 2, 3).
The analysis of the insoluble protein fraction showed
that after RI production with 6 to 12 mM DTT pro-
cessed RI appeared in the insoluble protein fractions of
both, dsbA+ and dsbA- strains (Figures 2, 3).
Despite the significantly higher amounts of soluble RI
achieved in the dsbA+ strain, RI activities in total protein
fractions of the dsbA- strain were just 10% lower. Inter-
estingly, if the analysis was performed with the periplas-
mic fractions only, the dsbA- strain constructs showed
even a 1.5 to 2-fold higher RI activity in comparison to
the dsbA+ strain (6 and 12 mM DTT, Figure 4).
The results of these experiments indicate that 12 mM
of DTT is optimal for RI production in dsbA- and dsbA+
strains. In contrast, GSH was not efficient for RI periplas-
mic accumulation. Thus it was not used in the further
experiments.
Analogous experiments with the second construct
group with the strongest promoters and ribosome bind-
ing sites (pCTUT7 constructs) also showed that the
addition of 12 mM DTT to the medium was optimal for
the RI production. However, compared to the first con-
structs, this second group resulted in a 4 to 5-fold lower
yield of active and soluble RI. Remarkably, no RI activity
Šiurkus and Neubauer Microbial Cell Factories 2011, 10:31
http://www.microbialcellfactories.com/content/10/1/31
Page 4 of 15
was found in the periplasmic protein fractions of the
dsbA+ and dsbA- strains of this second group of con-
structs (graphs not shown).
Cytoplasmic RI production with DTT
Based on the results with the periplasmic expression
vectors, which (i) clearly showed a positive effect of
DTT not only on the processed form of RI but also for
the unprocessed, i.e. signal peptide contaning form, we
expected that the same approach also should improve
the yield of cytoplasmically expressed RI. To evaluate
this we selected the E. coli RV308 pCUlac-His6-RI con-
struct which was earlier constructed (see [8]). In this
construct a 6× histidine tag is fused to the N-terminus
of RI. Otherwise this cytoplasmic construct is simlar to
the periplasmic production construct pCUlac-pelB-RI.
The experiments for cytoplasmic RI production were
performed analogously to the periplasmic expression
with addition of different amounts of DTT at the time
of induction. Here, clearly the RI activtiy was affected by
the synthesis temperature and the DTT concentration
(Figure 5). In more detail, DTT did not affect the yield
of soluble RI if the production was performed at 37°C
with all tested concentrations of DTT. Furthermore,
2 mM of DTT did not affect protein accumulation and
activity of RI in the soluble fraction, independently from
the synthesis temperature (Figure 5).
An obvious positive effect of DTT on the accumula-
tion and activity of RI in the soluble fraction was
detected if the production was performed at 30 or 22°C
with at least 6 mM DTT. RI activities were increased
by app. 30% compared to the controls without DTT.
Figure 2 SDS-PAGE images of total (T), soluble (S), or insoluble (IN) protein fractions of samples from shake flask cultures of E. coli
RV308 dsbA+ with the following periplasmic constructs: pCUvar-malE-RI (A, F), pCUvar-ompA-RI (B, G), pCUvar-phoA-RI (C, H) and
pCUlac-pelB-RI (D, I) 4 h after induction. Gels represent protein fractions after RI production without DTT (A-E) or with 12 mM DTT (F-J). Gels E
and J represent insoluble protein fractions of the constructs without DTT (E) or with 12 mM DTT (J). Numbered lanes: 1 - total protein fraction 10
min before induction, 2 and 3 - soluble and total protein fractions 4 h after induction. Numbered lanes in gels E and J represent the insoluble
fractions with the plasmids pCUvar-malE-RI (1A, 1F), pCUvar-ompA-RI (2B, 2G), pCUvar-phoA-RI (3C, 3H) and pCUlac-pelB-RI (4D, 4I). Protein size
marker: PageRuler™ Protein Ladder Plus (Fermentas). For growth conditions see Materials and Methods. The amounts of applied protein are
normalised.
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A slight improvement of the RI activity was also
observed even after production at 37°C with 12 and 18
mM of DTT (Figure 5). Indeed, the best results for cyto-
plasmic production were achieved after synthesis at 22°C
with 12 or 18 mM of DTT in the medium, correspond-
ing to ≈36 mg gCDW-1 and ≈620 kU gCWW-1 respec-
tively (Figure 5).
Interestingly, if the yields between cytoplasmic and
periplasmic cultures are compared, it is remarkable that
the amounts of soluble RI were highly similar to cyto-
plasmic yields in the best periplasmic production con-
structs. Surprisingly, the RI actvity was even 3-fold
higher with the cytoplasmic systems under comparable
conditions.
RI production in fed-batch shake flasks with EnBase
After the optimal conditions for periplasmic and cyto-
plasmic RI production were defined, the next challenge
was to test the effect of DTT on product accumulation
and folding in the bioreactor under fed-batch condi-
tions. Prior to the fed-batch bioreactor experiments the
RI periplasmic and cytoplasmic production with 12 mM
DTT in the medium were evaluated under fed-batch
conditions in shake flasks by applying the EnBase tech-
nology. The experiments were performed with the fol-
lowing constructs: (i) for the periplasmic production the
highest amount of processed and active RI yielding con-
structs: RV308 dsbA+ pCUlac-pelB and RV308 dsbA-
pCUvar-malE, (ii) for cytoplasmic production RV308
pCUlac-His6-RI.
All cultures performed with the dsbA+ strain showed a
2.6-fold improved RI production under the substrate
limited condition, in both, the periplasmic and cytoplas-
mic constructs. However, in contrast to the earlier per-
formed batch cultures, fed-batch production resulted
in a 15 to 20% lower amount of active RI per cell unit
(Figure 6). Under substrate limited conditions the dsbA-
strain grew very poorly and no product could be
detected. Therefore, aside from the cytoplasmic con-
structs, only the periplasmic expression construct
RV308(dsbA+) pCUvar-malE was used in the following
bioreactor experiments.
RI production in bioreactors
Finally, batch and fed-batch periplasmic and cytoplasmic
production of RI was performed in a stirred bioreactor.
Figure 3 SDS-PAGE images of total cell extracts (T), soluble (S), or insoluble (IN) protein fractions from periplasmic production
constructs of E. coli RV308 dsbA-. For vectors and conditions see Fig. 2.
Šiurkus and Neubauer Microbial Cell Factories 2011, 10:31
http://www.microbialcellfactories.com/content/10/1/31
Page 6 of 15
In batch cultivations induction was performed at an
OD600 of 7 (μ≈0.45 h
-1). In all fed-batch processes RI
production was induced during the glucose-limited
growth phase with exponential feeding at an OD600 of
app. 28 (μ≈0.22 h-1). After induction the feeding rate
was further increased according to the predetermined
feed function with the same μset as before induction.
Also DTT was added at the time of induction as in the
earlier experiments and concomitantly the temperatre
was decreased from 37 to 22°C (Figure 7).
DTT is inactivated during bioreactor cultivation with a
faster rate compared to shake flask cultures where the
DTT oxidation rate was very low (Figure 8). After 4
hours of RI production in shake flasks only 5 to 10% of
DTT was oxidized. In contrast more than 50% of DTT
were oxidized during bioreactor cultivation already after
3 h. Therefore different approaches were tested and
compared to keep the reduced state in the culture: (i)
Single pulse addition of DTT to a final concentration of
12 mM at the induction point, (ii) single pulse addition
of DTT to a final concentration of 12 mM 2 h after RI
induction, and (iii) repeated (3 times) addition of DTT,
starting at 2 h after induction (Figure 7).
Additionally, in order to prevent rapid DTT oxidiza-
tion in all processes at the DTT addition point, the air
flow was reduced from 30 L min-1 to 2 to 3 L min-1 to
maintain the oxygen concentration in the medium close
to zero. The reduction of the air flow was a necessary
condition for accumulation of active product. Only at an
reduced air flow rate the additon of DTT provoked a
clear positive effect with highest yields, and interestingly
this worked for both, the periplasmic and the cytoplas-
mic expression systems. However, despite a 30-fold
higher volumetric productivity in the fed-batch bioreac-
tor processes compared to the analogous batch pro-
cesses, the periplasmic and cytoplasmic RI yields per
cell remained 10 to 15% lower in the fed-batch cultiva-
tions with the same DTT addition mode (Figure 9).
Protein activity analysis in the crude extracts of sam-
ples from the fed-batch cultures revealed - different
from the shake flasks - that RI activity was only
improved by 1.4-fold by single DTT addition, but 2 to
3-fold when the repeated DTT addition approach was
applied (Figure 9). This is not surprising, because even
the minimum air flow, maintaining 0% of oxygen con-
centration in the medium, resulted in 60% of DTT oxi-
dation during the whole bioreactor process (Figure 8).
Discussion
In this work, for the first time, low molecular weight SH
group modifying agents were utilized for periplasmic
and cytoplasmic folding improvement of a cysteine-rich
LRR model protein with exclusively reduced cysteins, a
recombinant ribonuclease inhibitor (RI). We demon-
strated the effect of SH group modifying agents on peri-
plasmic and cytoplasmic activities of RI and its soluble
accumulation. We also showed that the reason for the
non-successful approaches for expression of active RI in
E. coli is its incapability to create an optimal redox
environment for RI folding even in the cytoplasm. In
addition, obviously RI folding in vivo does not just
depend on the redox conditions. Only the combination
of lower translation rate, low post-induction tempera-
ture and strongly reducing conditions resulted in a rea-
sonable yield of RI and these conditions could be
applied for periplasmic as well as for cytoplasmic RI
production. Furthermore, on the basis of these princi-
ples, which were evaluated in small-scale cultures, pro-
duction of RI was also successful during fed-batch
cultivation in a stirred tank bioreactor.
Figure 4 RI protein activities in total soluble and periplasmic
fractions after 4 h of batch RI production in different E. coli
RV308 dsbA+ (A) and dsbA- (B) constructs at 22°C with 0, 2, 6,
12 or 18 mM of DTT. Culture conditions: glucose-MSM medium,
induction with 0.2 mM IPTG, preinduction temperature 37°C, shift to
the respective temperature at the time of induction.
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Screening of the best constructs for soluble production
of RI
In the first part of the work, for evaluation of signifi-
cance of keeping reduced conditions, RI folding was
compared by expressing RI in the periplasmic compart-
ment of the E. coli K-12 strain RV308 and its isogenic
dsbA- mutant. This approach was based on the well
known fact that the redox status in the periplasm could
be easily controlled by the addition of SH group stabiliz-
ing agents, such as DTT and GSH, to the cultivation
medium. However, previous approaches mostly aimed
for optimising the redox conditions for disulfide bond
isomerisation (e.g. [12-16]). As a first step, however, we
tested whether different combinations of promoter,
ribosome binding site and signal sequences stipulate
soluble RI accumulation in periplasmic space as a kind
of initial standard conditions. Therefore we applied a
previously published plasmid library for periplasmic pro-
duction together with a periplasmic folding reporter sys-
tem [16]. The periplasmic RI folding in all production
constructs was evaluated by using the experimental set
up published recently by Šiurkus et al. [8], combining
fed-batch RI production in MWPs with luminescence
based high throughput screening. Interestingly, and in
difference to the earlier published results with the
screening for soluble human epidermal growth factor
receptor and human 11b-hydroxysteroid dehydrogenase
type 2, in case of RI the screening results did not match
Figure 5 RI protein activities in total soluble fractions (A) and SDS-PAGE images of normalised total (T), soluble (S) and insoluble (IN)
cell extracts (B) after 4 h of batch cytoplasmic RI production in shake flask batch cultures in E. coli RV308 pCUlac-His6-RI at 22°C with
0, 2, 6, 12 or 18 mM of DTT. Lanes in (B): 1 - total protein fraction 10 min before induction, lanes 2 to 4 - soluble, total and insoluble protein
fractions 4 h after induction. Gels represent protein fractions after 4 h of RI production without DTT at 37°C (gel 1) or 22°C (gel 2), or with 12
mM DTT at 37°C (gel 3) or 22°C (gel 4).
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with the soluble product amount in the periplasmic
space. In our case the weaker expression elements har-
bouring periplasmic production constructs gave higher
luminescence signals compared to the strong pCTUT7
constructs. We suggest that in case of very poor product
solubility, and thus high luminescence signals already in
the weaker expression vectors, lower luminescence in
the stronger expression vectors is a result of lower luci-
ferase production by an overloaded cellular production
machinery. Accordingly, the strongest growth inhibitory
effect was observed for the pCTUT7 constructs in
which the expression of luciferase was lowest. Weaker
expression stipulating constructs (promoters pC-, pCU-,
RBS: -lac, -var) resulted in high luminescence signals
during periplasmic RI production because a part of the
product was found in periplasmic inclusion bodies on
one side, but on the other side the weaker target protein
expression in these vectors did not consume all cellular
recourses needed for luciferase production and cellular
growth. Thus in summary, luciferase signals in combina-
tion with the periplasmic library have to be evaluated
with caution.
As the initial screening results provided no clear
answer on the preferable constructs, both, a strong and
a weaker expression construct were selected for the
further studies. As the previous results [8] indicated
aggregation in the cytoplasm as a major problem, the
following work was focussed on the control of the redox
conditions. This was parallel approached by using a
dsbA- mutant to remove of the strong oxidising activity
of DsbA, and in parallel applying reducing agents. Inter-
estingly, in our case GSH was not active, neither in the
dsbA+ nor in the dsbA- mutants. However, in contrast
DTT worked well. More favourable conditions for RI
folding in the periplasmic space were created in the
dsbA- mutant, but this mutant seemed also to be highly
sensitive to DTT and could not be productive in the
presence of higher concentrations than 6 mM DTT. By
considering all results of the separate analysis of the
amounts of processed (i.e. without signal peptide) and
non-processed forms of RI (i.e. with signal peptide), we
conclude that RI accumulation in the periplasmic space
was improved due to the primary effect of DTT on the
cytoplasm, where it avoided aggregation of the protein,
even in the case of cytoplasmic RI expression vectors.
The significance of the synthesis rate of RI for its peri-
plasmic accumulation and folding was clearly demon-
strated from RI periplasmic production experiments
with DTT in the strong and weak expression stipulating
constructs groups. The results showed that DTT was
highly effective only in weaker expression rate stipulat-
ing constructs, the balance between the synthesis and
the folding rate is important for obtaining soluble pro-
duct. In contrast DTT was not effective for RI folding in
the strong expression elements harbouring constructs in
which obviously the RI synthesis rates were too high.
The leader peptide had a lower impact on the accu-
mulation of processed RI. For further studies the pelB
leader peptide was selected as the most suitable for RI
periplasmic accumulation in dsbA+ strain. However, also
the ompA, malE and phoA leader peptides stipulated the
periplasmic accumulation of RI in the presence of DTT.
Our results are in good agreement with other periplas-
mic production cases. For example the significance of
synthesis rate on periplasmic accumulation and aggrega-
tion of recombinant penicillin G acylase was also
demonstrated by Sriubolmas et al. [18]. The authors
showed that the cytoplasmic and periplasmic aggrega-
tion of penicillin G acylase depend on the synthesis
rate, which was altered by varying the amounts of IPTG.
Figure 6 RI protein activities in total soluble and periplasmic
fractions [in kU (gCWW)-1] of E. coli RV308 pCUlac-pelB-RI and
E. coli RV308 pCUlac-His6-RI after EnBase cultivation in shake
flasks with RI induction for 4 h at 22°C without or with 12 mM
DTT (A), and SDS-PAGE images of total (T), soluble (S) and
insoluble (IN) protein extracts (normalised to equal amounts
protein) (B). Left gel: E. coli RV308 dsbA+ pCUlac-pelB-RI
(periplasmic expression construct); right gel: E. coli RV308 pCUlac-
His6-RI (cytoplasmic production construct). Lanes: 1 - total protein
fraction 10 min before induction, 2 to 4 - soluble, total, and
insoluble protein fractions 4 h after induction with 12 mM of DTT.
Protein size marker: PageRuler™ Protein Ladder Plus (Fermentas).
Data originate from three experiments.
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In addition, RI accumulation patterns, obtained after RI
synthesis with DTT, represented by premature and pro-
cessed RI forms in the insoluble and soluble protein frac-
tions, are typical for periplasmic production. Similar
pattern were reported by Sriubolmas et al. [18] for peni-
cillin G acylase and by Bowden et al. [19] for b-lactamase.
In both cases a mixture of precursor polypeptides with
signal peptides and processed periplasmic proenzyme
forms was detected.
Finally, another interesting optimisation case may be
mentioned, involving the same vector library and the
periplasmic misfolding reporter. Soluble periplasmic
accumulation of human 11b-hydroxysteroid dehydro-
genase type 2 and scFv-miniantibody phosphatase was
highly dependent on the leader peptide but not on the
expression rate regulating genetic elements. Indeed,
lower periplasmic aggregation levels and more efficient
export to the periplasmic space were observed for the
constructs with the weaker pCU promoter and the lac
ribosome binding site, compared to the strong expres-
sion pCUT7 vectors. [16]
The effect of DTT on the RI cytoplasmic folding
The RI activity was clearly dependent on the DTT con-
centration in the medium. Additionally, besides DTT,
cytoplasmic folding of RI strongly depended on the pro-
duction temperature as a synthesis rate and folding reg-
ulating factor. Even when RI production was carried
from a weaker promoter and ribosome binding site, the
lower production temperature stipulated a better RI
Figure 7 Growth curves of E. coli RV308 pCUlac-pelB-RI (periplasmic expression construct) and E. coli RV308 pCUlac-His6-RI
(cytoplasmic production construct) without (control) and with RI production in a batch and a fed-batch process with exponential
glucose feeding in a 10 L bioreactor. For conditions see Material and Methods. Black symbols: control culture without induction; red symbols:
batch bioreactor cultivation, blue symbols: fed-batch bioreactor cultivation.
Figure 8 The amount of reduced DTT during batch shake flask and fed-batch bioreactor processes with microarerobic production
mode, was measured by using Measure-iTTM Kit (Invitrogen). The samples for reduced DTT evaluation were taken every synthesis hour
starting with DTT addition moment. The data is derived from three assays.
Šiurkus and Neubauer Microbial Cell Factories 2011, 10:31
http://www.microbialcellfactories.com/content/10/1/31
Page 10 of 15
folding. Compared to best periplasmic production
results, the cytoplasmic production construct gave 3 to
4-fold higher total RI activity, although just 30% less
premature RI was produced in the best periplasmic pro-
duction construct. We suggest that the non-processed
N-terminal signal sequence, which is 3-fold longer com-
pared to the 6× His-tag can negatively affect the ability
of RI to interact with Rnase E. A negative effect of an
N-terminal tag on the activity of RI was also observed
after RI production as a fusion with MBP where the RI
specific activity was about 12-fold reduced (Šiurkus
unpublished data).
In our opinion, the RI solubility was improved due to
the complex DTT effect on (i) RI SH groups and (ii)
reduced expression rate stipulated by DTT toxicity,
genetic elements and lower production temperature.
Without doubt DTT could also have a negative impact
on the overall target protein yield due to the highly
induced stress related proteins as reported by Han et al.
[20]. Gill et al. [15] reported increased protease activities
and heat shock protein synthesis in E. coli JM105 and
RR1 strains after recombinant CAT production in a
bioreactor due to the presence of relatively low amounts
of DTT in the medium. Surprisingly our strain demon-
strated a comparably high tolerance to DTT. It was still
very productive in the medium containing a total DTT
concentration of close to 20 mM which according to
Missiakas et al. [21] should be a lethal for E. coli.
Interestingly, DTT served as an SH group modifier in
vivo not just in the periplasmic space but also in the
cytoplasm. It was obvious from the cytoplasmic produc-
tion results that the redox environment in the E. coli
cytosol is not optimal for a target protein with a high
content of reduced cysteins. The E. coli cytoplasmic
environment is in general reduced, but oxidative damage
occurs when cells enter the stationary phase and starva-
tion [22,23]. That would possibly lead to target protein
SH group oxidation.
RI fed-batch production in shake flasks
Enbase experiments provided valuable information for
the process development in the bioreactor. The dsbA-
strain turned out to be inable to maintain its productiv-
ity under substrate limited feed conditions with DTT
and thus would not be favorable for futher bioprocess
development. In contrast the cytoplasmic and periplas-
mic fed-batch production patterns in the constructs
with the dsbA+ strain with 12 mM of DTT were similar
to the batch shake flasks, showing that the substrate
limited cultivation mode has no negative effect on the
host productivity and protein folding in our case. Thus
Enbase clearly helped to save time and labor in hte pro-
cess develpment process.
Bioreactor processes
The bioreactor experiments showed that highly aerated
cultivation medium could be a very oxidative environ-
ment. That should be considered when compounds
which are sensitive to oxidation are used for protein
folding, recombinant synthesis induction and/or plasmid
stabilization. Microaerobic or fully anaerobic production
strategies would preserve more oxidation sensitive che-
micals. On the over hand respiration is a key factor for
recombinant productivity. Anaerobic conditions gener-
ally result in poor growth and are often considered as
unfavourable for recombinant protein production, by
limited energy production, acidification of the cytoplasm
by organic acids and the large synthetic requirements
which are needed to establish the anaerobic responses
[17,24,25]. Accordingly, we did not succeed to produce
RI when the air flow was downregulated at the induc-
tion point, however, we could solve the problem by later
addition of DTT and concomittant reduction of the
airflow.
In our case DTT oxidation in the bioreactor was the
main concern during development of the bioreactor pro-
cess. We succeeded to prevent rapid DTT oxidation,
which was obvious if the DO was maintained at
approximately 30%, by strongly reducing the aeration.
Thus we created conditions which are usually present in
shake flasks [17]. After medium supplementation with
DTT the air flow was not completely switched off, but
down-regulated in order to maintain the actual oxygen
concentration close to 0%.
This down-regulation of the air flow rate had a drastic
effect on the cell productivity when it was performed at
Figure 9 RI activities in the total soluble protein fraction (white
bars) and in the periplasmic fraction (grey bars) of E. coli of
RV308 pCUlac-pelB-RI and RV308 pCUlac-His6-RI from samples
of batch and fed-batch bioreactor cultivations without and
with addition of DTT. Data derive from three activity assays.
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the same time with DTT addition and RI synthesis
induction. In this case no RI production was found in
periplasmic and cytoplasmic constructs. In our opi-
nion the combination of temperature reduction,
induction and DTT addition stipulated a huge meta-
bolic burden as earlier defined by Glick [26]. In order
to reduce the stress, we decided to induce recombi-
nant production separately from medium supplemen-
tation with DTT and down-regulation of the air flow.
Thus only the temperature shift was performed at the
time of induction, but the reducing agent was added
only 2 hours after induction when the RI production
reached its maximum, and at the same time the air
flow was reduced.
Furthermore, unexpectedly, after single medium sup-
plementation with DTT much lower RI activity per cell
unit was detected in the bioreactor production process
compared to the shake flasks. However, the total RI pro-
duction level per cell unit in the bioreactor was similar
to the shake flask results. We suspected that the
decreased RI activity in the bioreactor could be related
to the partial oxidation of the DTT even at the very low
air flow rate, as confirmed by the analysis of the DTT
oxidation rate. Whereas during RI production only 10%
of the DTT was oxidized in shake flasks, 60% was found
to be oxidised in the bioreactor even at microaerobic
conditions. To counteract this we tested whether
repeated DTT addition would improve the yield of
active RI. As expected, repeated DTT addition strongly
enhanced RI folding during batch and fed-batch pro-
cesses. In this case the amount of active RI per cell unit
in the bioreactor processes was similar to the activities
which were detected in samples from shake flasks. The
effective RI production with DTT under batch and fed-
batch conditions shows that the in vivo approach for RI
folding is reproducible, independently from the cultiva-
tion mode and cell densities.
Conclusions
In this study we demonstrate the successful production
of active RI by periplasmic and cytoplasmic approaches
based on the artificial control of the redox conditions
and the expression rate via external manipulations with
medium components and cultivation parameters. The
folding approach presented here could be very useful for
recombinant protein production not just distinguished
by reduced SH groups but also for disulfide bond con-
taining proteins. In our opinion the combination of oxi-
dised/reduced DTT in tandem with the cellular
oxidation/reduction machinery and cultivation para-
meters could enhance oxido-(re)shuffling needed for
correct formation disulfide bonds in the cytoplasm. Our
folding approach could be applied as an alternative for
protein synthesis in the periplasmic compartment where




A previously described periplasmic expression library
[16], containing 36 periplasmic expression vectors, was
kindly provided from Hans-Knöll-Institute, Jena, Ger-
many. The RI encoding gene was inserted into periplas-
mic expression vectors via site specific recombination
reaction based on the Gateway® cloning technology
(Invitrogen) as described by [8].
Preparation of target protein expression platforms
The expression strain E. coli K-12 RV308 (ATCC 31608)
was first transformed by using the calcium temperature
shock method with the periplasmic folding stress repor-
ter plasmid plt1 previously described by Kraft et. al.
[27], carrying a resistance for ampicillin, and plated on
LB agar with ampicillin (100 μg mL-1). RV308 plt1 was
co-transformed with the library of 36 the RI gene con-
taining periplasmic expression vectors. The transfor-
mants were plated on LB agar containing ampicillin
(100 μg mL-1) and chloramphenicol (30 μg mL-1). The
cell stock was produced after 8 h of recombinant strain
cultivation in 10 mL of LB medium in 100 mL shake
flasks at 37°C and 220 rpm. All culture suspensions with
OD600 of 4 ± 0.2 were mixed with an equal volume of
sterile 50% glycerol solution to achieve a final glycerol
concentration of 25%. The glycerol culture suspensions
were aliquoted into sterile PCR strips and stored at
-70°C. For RI cytoplasmic expression experiments the
previously described RI expression construct RV308/
pCUlac-His6-RI [8] was used.
Engineering of E. coli RV308 dsbA- strain
The dsbA gene in RV308 was in inactivated by P1 trans-
duction. E. coli JW3832 from Keio collection was used
as the donor for the ΔdsbA::kan marker. The RV308
clones harboring ΔdsbA::kan were selected after cultiva-
tion on solid LB medium containing kanamycin antibio-
tics. In addition, the mutation in selected clones was
confirmed by PCR analysis, with the following forward
and reverse primers: 5’-aagatttggctggcgctggct-3’ and 5’ -
tcggacagatatttcactgtatca - 3. The strains - RV308 dsbA+
and JW3832 ΔdsbA::kan were used as controls in the
PCR analysis.
Cultivation media
Transformations and plasmid propagations were per-
formed on solid and liquid LB medium containing
Bacto-Tryptone (10 g L-1), Bacto-yeast extract (5 g L-1),
NaCl (10 g L-1), 15 g L-1 bacto agar (if solid medium)
and the required antibiotics. Fed-batch and batch culti-
vations were performed in glucose-based mineral salt
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medium (MSM) with the following composition (per
litre): Na2SO4 2 g, (NH4)2SO4 2.68 g, NH4Cl 0.5 g,
KHPO4 14.6 g, NaH2PO4×H2O 3.6 g, (NH4)2-H-citrate
1.0 g, and glucose 2.5 to 15 g. NaOH (40%) was used to
adjust pH to 7.0 prior heat sterilisation. Additionally,
before cultivation on the mineral salt medium the fol-
lowing sterile solutions were added: 3 mL L-1 of (1 M)
MgSO4 and 2 mL L
-1 of trace element solution with the
following composition (per litre): CaCl2×2H2O 0.5 g,
ZnSO4×7H2O 0.18 g, MnSO4×H2O 0.1 g, Na2-EDTA
20.1 g, FeCl3×6H2O 16.7 g, CuSO4 × 5H2O 0.16 g,
CoCl2 × 6H2O 0.18 g; and thiamine hydrochloride
(0.1 mM), ampicilin (100 mg L-1) and chrolamphenicol
(30 mg L-1). The feeding solution for fed-batch cultiva-
tions was based on fully formulated MSM with the
required antibiotics and 550 g L-1 of glucose.
Fed-batch mode cultures and recombinant protein
synthesis in 96 microwell plates
Agar based EnBase® 96 microwell plates (MWPs) were
purchased from BioSilta Oy Oulu (Finland). For cultiva-
tions in MWPs 10 μl of glycerol stock cultures were
transferred to cultivation wells containing 150 μl of fully
formulated MSM medium with 6 AGU L-1 of EnzI’m
(BioSilta Oy). Periplasmic RI expression was induced
after 10 hours of cultivation at 30°C at an OD600 of
12 ± 2 (μ ≈ 0.16 h-1) by addition of IPTG (0.2 mM final
concentration). All microscale cultures were cultivated
by intensive shaking with a Variomag® Thermoshake
(Inheco, Germany), shaking diameter 1.5 mm, at 30°C
and 750 rpm. After induction the temperature was
decreased to 22°C and the cultures were harvested 5 h
after induction. The OD600 measurements and the lumi-
nometric assay for assaying the target protein periplas-
mic misfolding levels in MWP’s were performed as
earlier described [8].
Batch mode cultivations in the shake flasks
The inoculums for batch protein production in shake
flasks were prepared by overnight batch cultivation of
the selected clones in 500 mL shake flaks with 50 ml of
glucose-MSM with 10 g L-1 of glucose at 37°C. For pro-
tein production 5% of the corresponding inoculum cul-
ture was transferred to fresh glucose-MSM containing
the same amount of glucose at a final volume of
200 mL in 1 L baffled Erlenmeyer flasks. Cultures were
grown at 37°C and 180 rpm until they reached a cell
density of OD600= 1 ± 0.05 (μ ≈ 0.35 h
-1) where induc-
tion was performed by addition of IPTG (final concen-
tration 0.2 mM). DTT was added to the cultivation
medium at the RI induction point as dry powder to
achieve the needed concentration of 2 to18 mM, and
reduced glutathione was added with a final concentra-
tion of 20 or 50 mM, respectively. The temperature was
shifted at the time of induction to 22°C and the cultures
were continued fro 4 h at the shaking rate of 180 rpm.
Fed-batch cultivations in shake flasks
The fed-batch shake flask cultivations were performed
with the gel-based EnBase system in 1 L baffled Erlen-
meyer flasks with 200 mL of MSM medium as earlier
described [8].
Glucose release for substrate limited growth was gen-
erated by 12 AGU L-1 in the cultivation medium. Pro-
duct synthesis in the selected expression platforms was
induced at OD600 = 5 ± 0.5 (μ ≈ 0.22 h
-1). Induction
was performed by addition of IPTG to a final concentra-
tion of 0.2 mM. The necessary amount of DTT was
added as dry powder to the cultivation medium to
achieve a final concentration of 12 mM. After induction
the cultures were continued for 4 h at 22°C at a shaking
rate of 180 rpm.
Bioreactor processes
Batch and fed-batch cultivations were performed in a
10 L working volume Biostat C bioreactor (B. Braun
Biotech, Melsungen, Germany) with the following para-
meters: the pO2 was maintained at 30% by adapting the
stirrer rate and automatic regulation of the air flow
(from 0 to 30 liters per min), the cultivation tempera-
ture before RI induction was 37°C. After induction it
was downregulated to 22°C and kept until the end of
the process. The pH was controlled at 7.0 ± 0.1 by addi-
tion of NH4OH (25%) or H3PO4 (2 M).
The feeding rate was controlled by the Biostat soft-
ware (version 4.62). The process was monitored by the
MFCS/win 2.0 supervisory system. Fed-batch cultiva-
tions were started with a volume of 8.0 L of MSM with
15 g L-1 of glucose. Exponential feeding profiles were
programmed to maintain a specific growth rate of μ ≈
0.22 h-1. The feeding profiles were calculated with fol-
lowing equations:
F(t) = Foeµt
where Fo is the initial feeding rate [L h
-1], μ is the spe-
cific growth rate [h-1] to be maintained during feed
operation, and t is the time after feed start [h]. The
initial feeding rate was calculated from the mass balance





Here, X0 and V0 are the cell dry weight (CDW) [g L
-1]
and the culture volume [L] at the time of the feeding
start, respectively, Sf [g L
-1] is the substrate concentra-
tion in the feeding solution, and Yx/s is the yield coeffi-
cient (g CDW per g of glucose). Yx/s in all cases
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(cytoplasmic and periplasmic expression strains) was
calculated from batch fermentations as 0.3 g g-1.
Before initiation of the fed batch mode cells were cul-
tivated as a batch until OD600 ≈ 18. RI synthesis was
induced during the fed-batch cultivation mode at an
OD600 of 28, the specific growth rate at the time of
induction was the same in all cases (μ = 0.22 h-1). The
exponential feed function was continued after induction
in all fed-batch experiments. Batch cultures were
induced at an OD600 of 7 (μ ≈0.45 h
-1).
In all bioreactor synthesis experiments 148 mL of 0.65
M DTT solution were added after 2 h of RI induction
to achieve a final concentration of 12 mM in the culti-
vation medium. In the experiments with DTT feeding
the same solution was added repeatedly, starting at
2 hours after RI induction by addition of 148 mL of
0.65 M DTT solution and continued by repeated addi-
tion of 74 mL 0.65 DTT solution every following
60 min. At the first DTT addition point the air flow was
decreased from 30 to 2-4 L min-1 and the stirrer was
manually regulated to maintain 0% of oxygen concentra-
tion in the cultivation medium. In all cases the target
protein synthesis continued for another 3 hours.
Analytical tools
Cell samples harvested from flask and bioreactor cultiva-
tions were resuspended in lysis buffer with the following
biomass to buffer ratio: 1 g of biomass with 10 mL of
lysis buffer (50 mM Tris-H3PO4 pH 8.0, 0.1% Triton X-
100, 2 mM EDTA, 1 mM PMSF, 15 mM DTT, 10% pro-
pyleneglycol and 0.1 mg mL-1 lysozyme). After 30 min
of lysis at +4°C the biomass was sonicated for 60 sec
(Vibra cell™, Sonic and Materials Inc., 6 mm diameter
probe tip) at 4°C. The soluble and insoluble protein
fractions were separated by centrifugation for 30 min,
14000 rpm, 4°C. The total protein fraction represents
cellular debris suspension (crude extract) before centri-
fugation. After centrifugation the insoluble protein pellet
was additionally washed and resuspended in the original
volume of lysis buffer without lysozyme. The periplas-
mic protein fractions were extracted by the standard
osmotic shock procedure. Therefore after centrifugation
the cell pellet was resuspended in 5 mL of ice cold solu-
tion, containing 20% (w/v) sucrose, 100 mM Tris-
H3PO4 (pH 8.0), and 0.5 mM Na2EDTA. After incuba-
tion for a 10 min at +4°C cells were harvested by centri-
fugation at 10,000 rpm for 10 min and +4°C. After
removal of the supernatant the cell pellet was again
resuspended in 5 mL of ice cold deionised water, con-
taining 15 mM of DTT. After another incubation for 10
min and centrifugation the supernatant (containing the
target protein) was suplemented with 2.0 ml of buffer
(250 mM Tris-H3PO4 pH 8.0, 0.4% Triton X-100, 8 mM
EDTA, 4 mM PMSF, 30% propylene glycol).
Samples for SDS-PAGE separation were prepared as
follows: 20 μL of protein sample (total soluble, insoluble,
protein suspensions), 25 μL of 4×SDS-PAGE loading
buffer (Fermentas), 5 μL of 20×DTT (Fermentas) and 50
μL of deionised water to obtain a final sample volume
of 100 μL. Samples were heated for 15 min at 95°C. 10
μL of sample was applied to each lane of a 10% SDS-
PAGE gel.
The amounts of target were determined from scanned
SDS-PAGE gel images with TotalLab software. The gels
with separated sample proteins were produced for
TotalLab quantifications with internal BSA standards (3
concentration points).
The amount of active RI in the soluble fraction was
determined by an activity assay described by Blackburn
et al. [28] and is presented in kilo units per gram cell
wet weight (kU gCWW-1). 1 mg of RI corresponds to
100 kU [28].
The N-terminal amino acid sequence of processed RI
was determined by the Edman degradation procedure in
Biocentrum Ltd. (Krakov, Poland) from insoluble pro-
tein fraction sample after RI production with DTT in
the medium and separation on an 8% SDS-PAGE gel.
The amount of oxidized/reduced DTT in the cultiva-
tion medium was determined with the Measure-iT™
Thiol Assay kit (Invitrogen), by following the producer’s
recommendations.
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